You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clovis

Showing 1 - 25 of 139
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Survivorship Trial in Clovis (Geriatric Assessment)

Recruiting
  • Survivorship
  • Geriatric Assessment
  • Clovis, California
    Community Cancer Institute
Mar 22, 2022

Prostate Cancer Trial in Salt Lake City (Rucaparib)

Active, not recruiting
  • Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 23, 2022

Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission

Recruiting
  • Solid Tumors, Adult
  • Metastatic Cancer
  • Gallium-68 labelled (68Ga-) FAP-2286
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 1, 2022

Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
  • +1 more
Nov 22, 2022

Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography

Recruiting
  • Liver Fibrosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2022

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Leiomyosarcoma Trial in United States (Rucaparib, Nivolumab)

Active, not recruiting
  • Leiomyosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Sep 6, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022

Breast Cancer Trial in United States (Rucaparib, Radiotherapy)

Active, not recruiting
  • Breast Cancer
  • Norwalk, Connecticut
  • +7 more
Aug 31, 2022

Small Cell Lung Cancer Trial in Lexington (Rucaparib and Nivolumab)

Recruiting
  • Small Cell Lung Cancer
  • Rucaparib and Nivolumab
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Aug 9, 2021

Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Uterine Carcinosarcoma
  • New York, New York
  • +2 more
Apr 4, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Metastatic Breast Cancer Trial in Lyon, Marseille (rucaparib)

Completed
  • Metastatic Breast Cancer
  • Lyon, France
  • +1 more
Jun 5, 2021

Stage IV NSCLC Trial in Ann Arbor, Saint Louis, Columbus (Pembrolizumab, Pemetrexed, Carboplatin)

Recruiting
  • Stage IV Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
  • +2 more
Oct 4, 2021

Solid Tumor, Unspecified, Adult Trial in San Francisco (Rucaparib, Irinotecan)

Completed
  • Solid Tumor, Unspecified, Adult
  • San Francisco, California
    University of California San Francisco
Mar 2, 2021

Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

Recruiting
  • Esophagus Cancer, Adenocarcinoma
  • Stomach Cancer, Adenocarcinoma
  • Chicago, Illinois
  • +7 more
Jan 31, 2022

Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)

Completed
Has Results
  • Opioid Dependence
  • Acute Opioid Withdrawal Syndrome
  • Lofexidine HCl
  • +2 more
  • Clovis, California
  • +17 more
Mar 11, 2022

Prostate Cancer, Endometrial Cancer Trial in Chicago (Rucaparib, Nivolumab)

Terminated
Has Results
  • Prostate Cancer
  • Endometrial Cancer
  • Chicago, Illinois
    University of Chicago Medical Center
Feb 15, 2021

Acute Myeloid Leukemia (AML) Trial in United States (Alvocidib (flavopiridol) and cytarabine (Ara-C), Alvocidib (flavopiridol))

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Alvocidib (flavopiridol) and cytarabine (Ara-C)
  • Alvocidib (flavopiridol)
  • Clovis, California
  • +17 more
Sep 22, 2022

Rucaparib in Rucaparib Access Program in Spain - A GEICO Study

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Almería, Andalucía, Spain
  • +22 more
Sep 22, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

    Withdrawn
    • Carcinoma, Non-small Cell Lung Cancer
    • nivolumab
    • +5 more
    • Detroit, Michigan
    • +22 more
    Mar 8, 2022

    End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)

    Completed
    • End Stage Renal Disease Requiring Hemodialysis
    • Clovis, California
    • +68 more
    Jan 20, 2023

    Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

    Active, not recruiting
    • Advanced Gastric Cancer
    • Nivolumab
    • +4 more
    • Phoenix, Arizona
    • +34 more
    Aug 18, 2022